Bosentan Cipla

Medicinal product

(Invented) name

Bosentan Cipla

Active substance (s)

Bozentanas

Strength

62,5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C02KX01, Bosentan

Marketing authorisation holder

UAB Viasana, Lietuva

Date of authorisation

2020-03-27

Date of renewal

Documents

1242_Bosentan Cipla 62,5mg_pl_deng_tab_PZPL_2020-03-27.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

tabletėje yra	1 vnt.
Bozentanas	62,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
103525	89627	1089627	lizdinė plokštelė	N56		Receptinis	LT/L/20/1242/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
	Išregistruotas
2020-03-27	Registruotas